Ebixa is a medicine that contains the active substance memantine hydrochloride. It is available as tablets (5 mg, 10 mg, 15 mg and 20 mg). Ebixa is also available as an oral solution, which is supplied with a pump that delivers 5 mg memantine hydrochloride with …

It is used alone or with other medications to treat people with moderate-to-severe Alzheimer's disease. Memantine does not cure Alzheimer's disease, but it is used to decrease the symptoms. It works in the brain to block the effect of some chemicals that cause symptoms of Alzheimer's disease such as decreased memory and other mental functions.

2025年1月7日 · The recommended maintenance dose of Ebixafor adults and older patients is 20 mg every day. In order to lower the risk of side effects, the dose should be achieved by upward titration with 5 mg per week over 3 weeks, achieving the maintenance dose of 20 mg/day from the start of week 4 according to the following dosage guideline:

Ebixa is a medicine that contains the active substance memantine hydrochloride. It is available as tablets (5 mg, 10 mg, 15 mg and 20 mg). Ebixa is also available as an oral solution, which is supplied with a pump that delivers 5 mg memantine hydrochloride with each activation.

2025年1月18日 · Memantine helps to ease the symptoms of dementia in Alzheimer's disease. Take one dose every day, at the same time of day each day. You can take memantine either before or after meals. You will be given a small dose when you first start treatment. This will gradually be increased over the following few weeks. Can memantine cause problems?

2021年12月13日 · The maximum daily dose is 20 mg once daily. In order to reduce the risk of undesirable effects, the maintenance dose is achieved by upward titration of 5 mg per week over the first 3 weeks as follows: Week 1 (day 1-7) The patient should take 0.5 ml solution (5 mg) equivalent to one pump actuation per day for 7 days. Week 2 (day 8-14)

2016年7月8日 · Ebixa , treatment was initiated at 5 mg/day and increased weekly by 5 mg/day to a dose of 20 mg/day (10 mg twice a day). Study Outcome Measures: In each study, the efficacy of Ebixa

2018年7月6日 · Ebixa acts on these NMDA-receptors improving the transmission of nerve signals and the memory. Ebixa is used for the treatment of patients with moderate to severe Alzheimer’s disease. 2.

Ebixa 5 mg/pump actuation oral solution. Oral solution. The solution is clear and colourless to light yellowish. Each pump actuation delivers 0.5 ml of solution which contains 5 mg of memantine hydrochloride which is equivalent to 4.16 mg memantine.

Ebixa is also available as an oral solution, which is supplied with a pump that delivers 5 mg memantine hydrochloride with each activation. What is Ebixa used for? Ebixa is used to treat patients with moderate to severe Alzheimer’s disease.